Reading Lab Certificates of Analysis (COA): HPLC Traces & Mass Spectrometry

The Role of Third-Party Analytical Verification

In high-purity peptide research, a Certificate of Analysis (COA) is the definitive proof of chemical identity and purity. High-caliber independent laboratories (such as Apex Labs) subject synthetic batches to rigorous orthogonal analytical testing, combining Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) with Electrospray Ionization Mass Spectrometry (ESI-MS).

Interpreting RP-HPLC Chromatograms

RP-HPLC determines the chromatographic purity percentage of the sample by separating molecules based on their hydrophobic interactions with a C18 silica stationary phase under an acetonitrile/water gradient containing 0.1% TFA.

• Retention Time (Rt): The duration required for the target compound to elute through the column. A sharp, symmetrical main peak demonstrates batch consistency.
• Area Under the Curve (AUC %): Purity is calculated by dividing the peak area of the target peptide by the total integrated peak area. Research-grade benchmarks require ≥99.0% AUC.
• Split Peaks or Shoulder Peaks: A secondary peak directly adjacent to the main retention peak typically signals truncated sequence fragments or diastereomeric impurities.

Mass Spectrometry (ESI-MS) Deconvolution

While HPLC confirms purity, Mass Spectrometry confirms compound identity by determining molecular mass down to single-dalton resolution:

• Theoretical Mass vs. Observed Mass: The theoretical monoisotopic or average molecular weight calculated from the amino acid sequence must match the deconvoluted ESI mass within a tight margin of error (±1.0 Da).
• Multi-Charge Ion Envelopes: Intact peptides produce multiply-charged species ([M+H]+, [M+2H]2+, [M+3H]3+). Deconvolution software reconstructs the uncharged parent molecular weight from these distribution peaks.

Endotoxin Testing & Visual Inspection

High-grade COAs also report Limulus Amebocyte Lysate (LAL) testing for bacterial endotoxins (measured in EU/mg), verifying that biological cell cultures will not suffer from lipopolysaccharide (LPS) artifacts during sensitive assay incubation.